Benoit Gourdier's Insider Trades & SAST Disclosures
Benoit Gourdier's most recent trade in Avantor Inc. was a trade of 86,565 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Benoit Gourdier.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avantor Inc. | Benoit Gourdier | EVP, Bioscience Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 86,565 | 86,565 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Benoit Gourdier | EVP, Bioscience Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 35,734 | 76,924 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Benoit Gourdier | EVP, Bioscience Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.30 per share. | 20 Feb 2025 | 2,842 | 74,082 (0%) | 0% | 17.3 | 49,167 | Common Stock |
| Avantor Inc. | Benoit Gourdier | EVP, Bioscience Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.54 per share. | 02 Oct 2024 | 1,263 | 41,190 (0%) | 0% | 25.5 | 32,257 | Common Stock |
| Avantor Inc. | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 62,753 | 62,753 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,667 | 42,453 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 39,281 | 39,281 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 16,786 | 16,786 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges